Literature DB >> 20847049

A novel p53 phosphorylation site within the MDM2 ubiquitination signal: II. a model in which phosphorylation at SER269 induces a mutant conformation to p53.

Jennifer A Fraser1, Arumugam Madhumalar, Elizabeth Blackburn, Janice Bramham, Malcolm D Walkinshaw, Chandra Verma, Ted R Hupp.   

Abstract

The p53 DNA-binding domain harbors a conformationally flexible multiprotein binding site that regulates p53 ubiquitination. A novel phosphorylation site exists within this region at Ser(269), whose phosphomimetic mutation inactivates p53. The phosphomimetic p53 (S269D) exhibits characteristics of mutant p53: stable binding to Hsp70 in vivo, elevated ubiquitination in vivo, inactivity in DNA binding and transcription, increased thermoinstability using thermal shift assays, and λ(max) of intrinsic tryptophan fluorescence at 403 nm rather than 346 nm, characteristic of wild type p53. These data indicate that p53 conformational stability is regulated by a phosphoacceptor site within an exposed flexible surface loop and that this can be destabilized by phosphorylation. To test whether other motifs within p53 have similarly evolved, we analyzed the effect of Ser(215) mutation on p53 function because Ser(215) is another inactivating phosphorylation site in the conformationally flexible PAb240 epitope. The p53(S215D) protein is inactive like p53(S269D), whereas p53(S215A) is as active as p53(S269A). However, the double mutant p53(S215A/S269A) was transcriptionally inactive and more thermally unstable than either individual Ser-Ala loop mutant. Molecular dynamics simulations suggest that (i) solvation of phospho-Ser(215) and phospho-Ser(269) by positive charged residues or solvent water leads to local unfolding, which is accompanied by local destabilization of the N-terminal loop and global destabilization of p53, and (ii) the double alanine 215/269 mutation disrupts hydrogen bonding normally stabilized by both Ser(215) and Ser(269). These data indicate that p53 has evolved two serine phosphoacceptor residues within conformationally flexible epitopes that normally stabilize the p53 DNA-binding domain but whose phosphorylation induces a mutant conformation to wild type p53.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20847049      PMCID: PMC2988382          DOI: 10.1074/jbc.M110.143107

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  67 in total

1.  Mutual dependence of MDM2 and MDMX in their functional inactivation of p53.

Authors:  Jijie Gu; Hidehiko Kawai; Linghu Nie; Hiroyuki Kitao; Dmitri Wiederschain; Aart G Jochemsen; John Parant; Guillermina Lozano; Zhi-Min Yuan
Journal:  J Biol Chem       Date:  2002-04-12       Impact factor: 5.157

2.  Mutant p53 cooperates with ETS and selectively up-regulates human MDR1 not MRP1.

Authors:  J Sampath; D Sun; V J Kidd; J Grenet; A Gandhi; L H Shapiro; Q Wang; G P Zambetti; J D Schuetz
Journal:  J Biol Chem       Date:  2001-08-01       Impact factor: 5.157

3.  Comparison of basis set effects and the performance of ab initio and DFT methods for probing equilibrium fluctuations.

Authors:  Ross C Walker; Ian P Mercer; Ian R Gould; David R Klug
Journal:  J Comput Chem       Date:  2007-01-30       Impact factor: 3.376

4.  p53 Antiproliferative function is enhanced by aspartate substitution at threonine 18 and serine 20.

Authors:  James R Jabbur; Wei Zhang
Journal:  Cancer Biol Ther       Date:  2002 May-Jun       Impact factor: 4.742

5.  Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: definition of mutant states for rescue in cancer therapy.

Authors:  A N Bullock; J Henckel; A R Fersht
Journal:  Oncogene       Date:  2000-03-02       Impact factor: 9.867

6.  Human p53 phosphorylation mimic, S392E, increases nonspecific DNA affinity and thermal stability.

Authors:  Nicole Magnasco Nichols; Kathleen Shive Matthews
Journal:  Biochemistry       Date:  2002-01-08       Impact factor: 3.162

7.  Role of Mdm2 acid domain interactions in recognition and ubiquitination of the transcription factor IRF-2.

Authors:  Susanne Pettersson; Michael Kelleher; Emmanuelle Pion; Maura Wallace; Kathryn L Ball
Journal:  Biochem J       Date:  2009-03-15       Impact factor: 3.857

8.  The absence of Ser389 phosphorylation in p53 affects the basal gene expression level of many p53-dependent genes and alters the biphasic response to UV exposure in mouse embryonic fibroblasts.

Authors:  Wendy Bruins; Oskar Bruning; Martijs J Jonker; Edwin Zwart; Tessa V van der Hoeven; Jeroen L A Pennings; Han Rauwerda; Annemieke de Vries; Timo M Breit
Journal:  Mol Cell Biol       Date:  2008-01-14       Impact factor: 4.272

9.  Xenopus laevis p53 protein: sequence-specific DNA binding, transcriptional regulation and oligomerization are evolutionarily conserved.

Authors:  Y Wang; G Farmer; T Soussi; C Prives
Journal:  Oncogene       Date:  1995-02-16       Impact factor: 9.867

10.  Transcription factor TAFII250 promotes Mdm2-dependent turnover of p53.

Authors:  N Allende-Vega; M K Saville; D W Meek
Journal:  Oncogene       Date:  2007-01-22       Impact factor: 9.867

View more
  8 in total

1.  Extensive post-translational modification of active and inactivated forms of endogenous p53.

Authors:  Caroline J DeHart; Jasdave S Chahal; S J Flint; David H Perlman
Journal:  Mol Cell Proteomics       Date:  2013-09-20       Impact factor: 5.911

2.  Impact of the adenoviral E4 Orf3 protein on the activity and posttranslational modification of p53.

Authors:  Caroline J DeHart; David H Perlman; S J Flint
Journal:  J Virol       Date:  2015-01-07       Impact factor: 5.103

3.  Investigating Conformational Dynamics and Allostery in the p53 DNA-Binding Domain Using Molecular Simulations.

Authors:  Elena Papaleo
Journal:  Methods Mol Biol       Date:  2021

4.  A novel p53 phosphorylation site within the MDM2 ubiquitination signal: I. phosphorylation at SER269 in vivo is linked to inactivation of p53 function.

Authors:  Jennifer A Fraser; Borivoj Vojtesek; Ted R Hupp
Journal:  J Biol Chem       Date:  2010-09-17       Impact factor: 5.157

5.  Mutational analysis of the multiple-antibiotic resistance regulator MarR reveals a ligand binding pocket at the interface between the dimerization and DNA binding domains.

Authors:  Valérie Duval; Laura M McMurry; Kimberly Foster; James F Head; Stuart B Levy
Journal:  J Bacteriol       Date:  2013-05-17       Impact factor: 3.490

6.  DNA-binding protects p53 from interactions with cofactors involved in transcription-independent functions.

Authors:  Matteo Lambrughi; Luca De Gioia; Francesco Luigi Gervasio; Kresten Lindorff-Larsen; Ruth Nussinov; Chiara Urani; Maurizio Bruschi; Elena Papaleo
Journal:  Nucleic Acids Res       Date:  2016-09-06       Impact factor: 16.971

7.  Molecular chaperones in the acquisition of cancer cell chemoresistance with mutated TP53 and MDM2 up-regulation.

Authors:  Zuzanna Tracz-Gaszewska; Marta Klimczak; Przemyslaw Biecek; Marcin Herok; Marcin Kosinski; Maciej B Olszewski; Patrycja Czerwińska; Milena Wiech; Maciej Wiznerowicz; Alicja Zylicz; Maciej Zylicz; Bartosz Wawrzynow
Journal:  Oncotarget       Date:  2017-06-30

8.  Simulations of mutant p53 DNA binding domains reveal a novel druggable pocket.

Authors:  Mohan R Pradhan; Jia Wei Siau; Srinivasaraghavan Kannan; Minh N Nguyen; Zohra Ouaray; Chee Keong Kwoh; David P Lane; Farid Ghadessy; Chandra S Verma
Journal:  Nucleic Acids Res       Date:  2019-02-28       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.